Log In
Print
BCIQ
Print
Print this Print this
 

SPI-5557

  Manage Alerts
Collapse Summary General Information
Company Sound Pharmaceuticals Inc.
DescriptionLocally injected short interfering RNA (siRNA) against cyclin dependent kinase inhibitor 1B (CDKN1B)
Molecular Target Cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationHearing loss
Indication DetailsTreat deafness and to induce regeneration of cochlear cells
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today